Related Experiment Video
Updated: Mar 1, 2026

A High-content Assay for Monitoring AMPA Receptor Trafficking
Published on: January 28, 2019
Amyloid beta-peptide inhibits Na+-dependent glutamate uptake
C M Lauderback1, M E Harris-White, Y Wang
1Department of Chemistry and Center of Membrane Sciences, University of Kentucky, Lexington 40506, USA.
Abstract:
The purpose of this review is to summarize much of the work on the inhibition of the astroglial glutamate transporter in relation to excitotoxic neurodegeneration, in particular, inhibition of uptake by the beta-amyloid peptide (A beta) found in the Alzheimer's disease (AD) brain. There is evidence for oxidative stress in the AD brain, and A beta has been found to generate reactive oxygen species (ROS), thus adding to the stress or possibly initiating it. The oxidative inhibition of the glutamate transporter protein by A beta increases the vulnerability of glutamatergic neurons, and by rendering them susceptible to the excitotoxic insult that results from impaired glutamate uptake, A beta can be directly connected to the neurodegeneration that follows.
Related Concept Videos
Antiepileptic Drugs: Glutamate Antagonists
Drugs Affecting Neurotransmitter Release or Uptake
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Drugs Affecting Neurotransmitter Synthesis
Neurochemical Transmission: Sites of Drug Action
Excitatory and Inhibitory Effects of Neurotransmitters

